Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors

MLA

Joon Seon Song, et al. “Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.” Frontiers in Oncology, vol. 9, Oct. 2019. EBSCOhost, https://doi.org/10.3389/fonc.2019.01055.

APA

Joon Seon Song, Deokhoon Kim, Ji Hyun Kwon, Hyeong Ryul Kim, Chang-Min Choi, & Se Jin Jang. (2019). Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors. Frontiers in Oncology, 9. https://doi.org/10.3389/fonc.2019.01055

Chicago

Joon Seon Song, Deokhoon Kim, Ji Hyun Kwon, Hyeong Ryul Kim, Chang-Min Choi, and Se Jin Jang. 2019. “Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.” Frontiers in Oncology 9 (October). doi:10.3389/fonc.2019.01055.